Live Poll Results — What innovative pricing strategy did Broad Institute and UC Berkeley initially a
See real-time poll results. Powered by AIPolls.Net.
Scientific Innovation Pricing: The Case of CRISPR
The commercialization of scientific breakthroughs involves complex pricing strategies that balance accessibility, research investment recovery, and ethical considerations. CRISPR gene-editing technology represents one of the most significant scientific advances of the 21st century, but its pricing and licensing have sparked debates throughout the scientific community. This poll tests your knowledge about how this revolutionary technology was brought to market.
What innovative pricing strategy did Broad Institute and UC Berkeley initially adopt for CRISPR technology licensing that helped accelerate scientific research?
Poll Type: Trivia | Total Votes: 0
| Option | Votes | Percentage |
|---|---|---|
| {'choice_text': 'Dual-tier licensing: free for academic research but commercial licensing fees for companies', 'is_correct': True} | 0 | 0% |
| {'choice_text': 'Blockchain-based micropayment system where researchers pay per successful edit', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Universal premium pricing with 5-year exclusive licensing to highest bidders', 'is_correct': False} | 0 | 0% |
| {'choice_text': 'Subscription model where labs pay monthly fees based on institution size', 'is_correct': False} | 0 | 0% |